Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate.Published in:Frontiers in Neurology, 2020, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.01045By:Honce, Justin M.;Nair, Kavita V.;Hoyt, Brian D.;Seale, Rebecca A.;Sillau, Stefan;Engebretson, Eric;Schurr, Brittany;Corboy, John R.;Vollmer, Timothy L.;Alvarez, EnriquePublication type:Article